Primary Open Angle Glaucoma (POAG) Clinical Trial
— TRASCOOfficial title:
Pilot Study to Compare the Humphrey Field Analyzer (HFA) 30-2 Swedish Interactive Threshold Algorithm (SITA) Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE), Using a New Fast GATE (German Adaptive Threshold Estimation) in Glaucoma Patients Under Topic Therapy
Verified date | January 2016 |
Source | University Hospital Tuebingen |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Observational |
The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.
Status | Active, not recruiting |
Enrollment | 12 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - primary open angle glaucoma (POAG) - spherical ametropia max. ± 8 dpt - cylindrical ametropia max. ± 3 dpt - distant visual acuity > 10/20 - pupil diameter > 3 mm Exclusion Criteria: - diabetic retinopathy - asthma - history of epilepsy or significant psychiatric disease - medications known to effect visual field sensitivity - infections (e.g., keratitis, conjunctivitis, uveitis) - severe dry eyes - miotic drug - squint - nystagmus - albinism - any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields - keratoconus - intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening - history or signs of any visual pathway affection other than glaucoma - history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Germany | Institute for Ophthalmic Research | Tuebingen |
Lead Sponsor | Collaborator |
---|---|
University Hospital Tuebingen | Alcon Research |
Germany,
Schiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagrèze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):488-94. doi: 10.1167/iovs.08-2229. Epub 2008 Dec 5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of rate of progression | Perimetric measures every 3 month over 3 years | 36 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01085357 -
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
|
N/A | |
Completed |
NCT02434692 -
Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)
|
N/A | |
Completed |
NCT02700984 -
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial
|
N/A | |
Recruiting |
NCT06016972 -
Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients
|
Phase 2 | |
Completed |
NCT01517477 -
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
|
N/A | |
Terminated |
NCT01180062 -
Safety Study of Latanoprost Slow Release Insert
|
Phase 1 | |
Terminated |
NCT03478293 -
iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications
|
N/A | |
Completed |
NCT01166659 -
Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy
|
N/A | |
Completed |
NCT01252849 -
Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
|
N/A |